Rx Medicare

Low-back pain continues to impose a huge burden on industrialized societies, in terms of symptoms, medical costs, productivity, and work absence. Annual costs related to back pain in the United States alone may run as high as $100 billion per year.

Read More…

Related Posts

• MicroTransponder Raises $10 Million To Begin Clinical Trials Of Wireless Neurostimulation For Chronic Pain And Obtain FDA Clearance
• First Results In United States In 20 Years From Clinical Trials Of Smoked Cannabis
• Usual Care Often Not Consistent With Clinical Guidelines For Low Back Pain
• Bharat Biotech Begins Phase I Clinical Trials Of HN-VAC – Its Cell Culture H1N1 Vaccine
• Validity of cost-effectiveness models based on randomized clinical trials
• Intensive, Progressive Physical Therapist Exercise Program Plus Educationreduces Disability And Improves Patient Function After Back Surgery
• CSL Biotherapies Announces Start Of U.S. H1N1 Vaccine Clinical Trials
• Incontinence, Breathing Problems And Gastrointestinal Disorders Predict Back Pain In Women
• Sinovac Reports Positive Preliminary Results For Clinical Trials Of H1N1 Vaccine
• Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
• Array BioPharma Announces Top-Line Results In Two Phase 1 Clinical Trials
• To Ease Aching Back, Exercise More, Not Less
• APS Healthcare And Thomson Reuters To Manage New York State’s Medicaid Clinical Best Practices Review Program
• Back Pain Treatment Needs To Catch Up With Evidence: Exercise And Other Proven Treatments Are Underused
• Imaging For Low-Back Pain Without Indication Of Serious Underlying Conditions Does Not Improve Clinical Outcomes

Tags: back, clinical, exercise, only, prevents, problems, review, trials

This entry was posted on Friday, February 27th, 2009 at 6:02 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.